Archives by Month:

Summary

AUDITOR’S SUMMARY Financial Statements, Fiscal Year Ended June 30, 2024 THE PRIMARY PURPOSE of the audit was to form an opinion on the fairness of the presentation of the financial statements for the Hawai‘i Housing Finance and Development Corporation, as of and for the fiscal year ended June 30, 2024, and to comply with the ...
Read More Financial and Compliance Audit of the Hawai‘i Housing Finance and Development Corporation

Summary

AUDITOR’S SUMMARY Financial Statements, Fiscal Year Ended June 30, 2024 THE PRIMARY PURPOSE of the audit was to form an opinion on the fairness of the presentation of the financial statements of the Department of Transportation, Harbors Division, as of and for the fiscal year ended June 30, 2024. The audit was conducted by Accuity ...
Read More Financial Audit of the Department of Transportation, Harbors Division

Summary

AUDITOR’S SUMMARY Financial Statements, Fiscal Year Ended June 30, 2024 THE PRIMARY PURPOSE of the audit was to form an opinion on the fairness of the presentation of the financial statements for the Hawai‘i Community Development Authority, as of and for the fiscal year ended June 30, 2024. The audit was conducted by KKDLY LLC. ...
Read More Financial Audit of the Hawai‘i Community Development Authority

Summary

AUDITOR’S SUMMARY WE WERE REQUESTED BY THE LEGISLATURE through House Concurrent Resolution No. 225 (Reg. Session 2024) to assess the social and financial effects of prohibiting insurers from requiring an insured diagnosed with stage 2 through stage 5 cancer to undergo step therapy prior to covering the drugs prescribed by the insured’s health care provider, ...
Read More 25-02, Study of Proposed Mandatory Health Insurance Coverage Regarding Step Therapy Requirements for Stage 2 Through Stage 5 Cancer

Summary

AUDITOR’S SUMMARY WE WERE REQUESTED BY THE LEGISLATURE through House Concurrent Resolution No. 53 (Reg. Session 2024), to assess the social and financial effects of mandating health insurance coverage for medically necessary biomarker testing as proposed in House Bill No. 2223, House Draft 1 (Reg. Session 2024) (HB 2223, HD 1) and in accordance with ...
Read More 25-01, Assessment of Proposed Mandatory Health Insurance Coverage For Medically Necessary Biomarker Testing